M. Catalán

IL-6–based mortality risk model for hospitalized patients with COVID-19

Rocío Laguna‐Goya, Alberto Utrero‐Rico, Paloma Talayero et al. · Journal of Allergy and Clinical Immunology · 2020 · 228 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +15

A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital

Francisco López‐Medrano, Manuel Lizasoaín, M. Catalán et al. · Clinical Microbiology and Infection · 2012 · 90 citations

Pharmacy, Infectious Diseases, Antimicrobial Pharmacotherapy +13

A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3) – β – d-glucan chromogenic assay in serum samples

Joshi Acosta, M. Catalán, Ángel del Palacio‐Pérez‐Medel et al. · Clinical Microbiology and Infection · 2010 · 76 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

Jordi Riera, Enric Barbeta, Adrián Tormos et al. · European Respiratory Journal · 2022 · 62 citations · Full text

Medicine, Infectious Diseases, Critical Care Medicine +16

Associations between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-acquired pneumonia

Jordi Rello, M. Catalán, María Bodi et al. · Intensive Care Medicine · 2002 · 58 citations

Pharmacy, Infectious Diseases, Antimicrobial Pharmacotherapy +13